The Nexus Select Trust REIT IPO was subscribed 0.57 times on Day 2. The issue received 10.5 crore bids for…
As Mankind Pharma shares fell 6% in trade today following its bumper listing on the bourses yesterday, analysts are mixed…
The company has filled the draft red herring prospectus (DRHP) with capital market regulator Securities and Exchange Board of India…
The Nexus Select Trust REIT IPO was subscribed 0.28 times on Day 1.
The Blackstone-backed Nexus Select Trust REIT IPO opened for subscription on 9 May. Should you subscribe to the Rs 3,200…
Mankind Pharma IPO: The pharma major’s shares had a bumper listing on the bourses as the shares debuted at a…
As per the regulatory filing on Monday, Nexus Select Trust has raised Rs 1,440 crore from anchor investors, which included…
Cainiao Network Technology’s initial public offering (IPO) plan comes after Alibaba flagged in late March it would split its business…
“We spend a lot of time on industrials given our experience in the sector and the ‘Make in India’ initiative…
In case a firm fails to launch IPO during this period, it has to refile the prospectus with the regulator…
Blackstone-backed Nexus Select Trust REIT settled on a price band at Rs 95-100 per unit for their public issue.
Tata Play, the first company in India to use the confidential pre-filing of draft papers option for an initial share…
Regulatory approval for an IPO is valid for a year.
Nexus Select Trust REIT Rs 3,200 crore IPO is set to open on May 9 and consists of both, a…
India reported the largest number of public issues floated in the first quarter of this year, driven by a large…
Mankind Pharma IPO was massively oversubscribed, at 15.3 times, at close yesterday.
The portion for retail investors remains undersubscribed as investors bid only 0.92 times of the shares reserved for RIIs. The…
Mankind Pharma’s IPO was fully subscribed at 2.13 times before the end of the third day of bidding.